Monotherapy Versus Combination Therapy Beyond 12 Months After Coronary Intervention in Older Atrial Fibrillation Patients

Masahiro Takita, Megumi Maeda, Futoshi Oda, Haruhisa Fukuda

Open source

DOI
10.1016/j.jacasi.2026.08.010
Published
2026-09
Container
JACC: Asia
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jacasi.2026.08.010,
  title = {Monotherapy Versus Combination Therapy Beyond 12 Months After Coronary Intervention in Older Atrial Fibrillation Patients},
  author = {Masahiro Takita and Megumi Maeda and Futoshi Oda and Haruhisa Fukuda},
  year = {2026},
  journal = {JACC: Asia},
  doi = {10.1016/j.jacasi.2026.08.010},
  url = {https://doi.org/10.1016/j.jacasi.2026.08.010}
}

RIS

TY  - JOUR
TI  - Monotherapy Versus Combination Therapy Beyond 12 Months After Coronary Intervention in Older Atrial Fibrillation Patients
AU  - Masahiro Takita
AU  - Megumi Maeda
AU  - Futoshi Oda
AU  - Haruhisa Fukuda
PY  - 2026
JO  - JACC: Asia
DO  - 10.1016/j.jacasi.2026.08.010
UR  - https://doi.org/10.1016/j.jacasi.2026.08.010
ER  - 

APA

Takita, M., Maeda, M., Oda, F., & Fukuda, H. (2026). Monotherapy Versus Combination Therapy Beyond 12 Months After Coronary Intervention in Older Atrial Fibrillation Patients. JACC: Asia. https://doi.org/10.1016/j.jacasi.2026.08.010

Source records